Determinants of uncontrolled dyslipidaemia among adult type 2 diabetes in Malaysia: The Malaysian Diabetes Registry 2009

Published:February 06, 2012DOI:


      Numerous studies with compelling evidence had shown a clear relationship between dyslipidaemia and cardiovascular (CV) events in patients with diabetes mellitus. This was an observational study based on secondary data from the online registry database Adult Diabetes Control and Management (ADCM) looking into the determinants of uncontrolled dyslipidaemia in type 2 diabetes mellitus patients. Independent predictors were identified using multivariate logistic regression. A total of 303 centres (289 health clinics, 14 hospitals) contributed a total of 70,889 patients (1972 or 2.8% patients were from hospital). About thirty eight percent were reported to have dyslipidaemia. There were 40.7% patients on lipid-lowering agents and of those above age 40 years old, only 38.1% of them were on a statin. Malay ethnicity and younger age groups (<50 years old) were two major determinants of uncontrolled LDL-C, TG and HDL-C. Female gender and uncontrolled blood pressure were determinants of uncontrolled LDL-C, and poor glycaemic control was related independently to high TG. This study has highlighted the suboptimal management of diabetic dyslipidaemia in Malaysia. Pharmacological treatment of dyslipidaemia could be more effective. Healthcare stakeholders in this country, especially in the primary care, have to recognize these shortfalls and take immediate remedial measures.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Haffner S.M.
        • Lehto S.
        • Rönnemaa T.
        • Pyörälä K.
        • Laakso M.
        Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
        N Engl J Med. 1998; 339: 229-234
        • Assmann G.
        • Schulte H.
        Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study.
        Am J Cardiol. 1992; 70: 733-737
        • Syvänne M.
        • Taskinen M.-R.
        Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus.
        Lancet. 1997; 350: S20-S23
        • Turner R.C.
        • Millns H.
        • Neil H.A.W.
        • Stratton I.M.
        • Manley S.E.
        • Mathews D.R.
        • et al.
        Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23).
        BMJ. 1998; 316: 823-828
        • Hokanson J.E.
        • Austin M.A.
        Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.
        J Cardiovasc Risk. 1996; 3: 213-219
        • Krentz A.J.
        Lipoprotein abnormalities and their consequences for patients with type 2 diabetes.
        Diabetes Obes Metab. 2003; 5: S19-S27
        • Verges B.
        New insight into the pathophysiology of lipid abnormalities in type 2 diabetes.
        Diabetes Metab. 2005; 31: 429-439
        • Taguchi S.
        • Oinuma T.
        • Yamada T.
        A comparative study of cultured smooth muscle cell proliferation and injury, utilizing glycated low density lipoproteins with slight oxidation, auto-oxidation, or extensive oxidation.
        J Atheroscler Thromb. 2000; 7: 132-137
        • Chan J.C.N.
        • Chan S.P.
        • Deerochanawong C.
        • Go R.T.
        • Lee K.O.
        • Ma R.C.
        • et al.
        Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: what we know and don’t know.
        Diabetes Res Clin Pract. 2011; : 1-13
        • Wang S.H.
        • Sun Z.L.
        • Ruan X.Z.
        • Guo Y.J.
        • Wang Y.
        • Jin H.
        • et al.
        Dyslipidaemia among diabetic patients with ischemic stroke in a Chinese hospital.
        Chin Med J. 2009; 122: 2567-2572
        • Johnson J.L.
        • Slentz Ca
        • Duscha B.D.
        • Samsa G.P.
        • McCartney J.S.
        • Houmard J.A.
        • et al.
        Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study.
        Atherosclerosis. 2004; 176: 371-377
        • Ahmed K.A-a Muniandy S.
        • Ismail I.S.
        • Ali R.S.
        Evaluation of N ɛ-(carboxymethyl) lysine and lipid peroxidation in multiethnic Malaysian subjects with type 2 diabetes mellitus.
        Sci Res Essays. 2011; 6: 1957-1962
        • Collins R.
        • Armitage J.
        • Parish S.
        • Sleigh P.
        • Peto R.
        MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
        Lancet. 2003; 200 (6): 5-201
        • Ballantyne C.M.
        • Olsson A.G.
        • Cook T.J.
        • Mercuri M.F.
        • Pedersen T.R.
        • Kjekshus J.
        Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.
        Circulation. 2001; 104: 3046-3051
        • Wens J.
        • Gerard R.
        • Vandenberghe H.
        Optimizing diabetes care regarding cardiovascular targets at general practice level: [email protected]
        Prim Care Diabetes. 2011; 5: 19-24
        • Gagliardino J.J.
        • Kleinebreil L.
        • Colagiuri S.
        • Flack J.
        • Caporale J.E.
        • Siri F.
        • et al.
        Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America.
        Diabetes Res Clin Pract. 2010; 88: 7-13
        • Chew B.H.
        • Khoo E.M.
        • Chia Y.C.
        Quality of care for adult type 2 diabetes mellitus at a University Primary Care Centre in Malaysia.
        Int J Collaborative Res Intern Med Public Health. 2011; 3: 439-449
        • Sazlina S.G.
        • Zailinawati A.H.
        • Zaiton A.
        • Ong I.
        A clinical audit on diabetes care in two urban public primary care clinics in Malaysia.
        Malays J Med Health Sci. 2010; 6: 101-109
        • Aekplakorn W.
        • Chariyalertsak S.
        • Kessomboon P.
        • Sangthong R.
        • Inthawong R.
        • Putwatana P.
        • et al.
        Prevalence and management of diabetes and metabolic risk factors in Thai adults: the Thai National Health Examination Survey IV, 2009.
        Diabetes Care. 2011; 34: 1980-1985
        • Ismail I.S.
        • Nazaimoon W.
        • Mohamad W.
        • Letchuman R.
        • Singaraveloo M.
        • Hew F.L.
        • et al.
        Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.
        Diabet Med. 2001; 18: 501-508
        • Wong J.
        • Tan F.
        • Lee P.
        The state of lipid control in patients with diabetes in a Public Health Care Centre.
        Asia Pac J Public Health. 2007; 19: 16-21
        • Abougalambou S.S.I.
        • Mohamed M.
        • Sulaiman S.A.S.
        • Abougalambou A.S.
        • Hassali M.A.
        Current clinical status and complications among type 2 diabetic patients in Universiti Sains Malaysia hospital.
        Int J Diabetes Mellit. 2010; 2: 184-188
        • Mastura I.
        • Chew B.H.
        • Lee P.Y.
        • Cheong A.T.
        • Shariff-Ghazali S.
        • Jamaiyah H.
        • et al.
        Control and treatment profiles of 70,889 adult type 2 diabetes mellitus patients in Malaysia.
        Int J Collaborative Res Intern Med Public Health. 2011; 3: 98-113
      1. Awin N. A Review of Primary Health Care in Malaysia—A Report for the World Health Organization Western Pacific Region. Ministry of Health, Malaysia; 2000, p. 6–23.

        • Health Technology Assessment Unit
        Clinical practice guidelines—management of hypertension.
        Ministry of Health Malaysia, Putrajaya2008
        • Health Technology Assessment Unit
        Clinical practice guidelines—management of type 2 diabetes mellitus (T2DM).
        Ministry of Health Malaysia, Putrajaya2009
        • Keech A.
        • Simes R.J.
        • Barter P.
        • Best J.
        • Scott R.
        • Taskinen M.R.
        • et al.
        Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
        Lancet. 2005; 366: 1849-1861
        • Mohamed E.
        • Mohamed M.
        • Rashid F.A.
        • Sciences M.
        • Kerian K.
        Dyslipidaemic pattern of patients with type 2 diabetes mellitus.
        Malays J Med Sci. 2004; 11: 44-51
        • Ramachandran A.
        • Ma R.C.
        • Snehalatha C.
        Diabetes in Asia.
        Lancet. 2010; 375: 408-418
        • Shaw J.E.
        • Sicree R.A.
        • Zimmet P.Z.
        Global estimates of the prevalence of diabetes for 2010 and 2030.
        Diabetes Res Clin Pract. 2010; 87: 4-14
        • Roglic G.
        • Unwin N.
        Mortality attributable to diabetes: estimates for the year 2010.
        Diabetes Res Clin Pract. 2010; 87: 15-19
        • International Diabetes Federation
        Diabetes atlas.
        Fourth edition. 2010
        • Starfield B.
        Challenges to primary care from co- and multi-morbidity.
        Prim Health Care Res Dev. 2011; 12: 1-2
        • Olafsdottir E.
        • Aspelund T.
        • Sigurdsson G.
        • Thorsson B.
        • Eiriksdottir G.
        • Harris T.B.
        • et al.
        Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study.
        BMJ Open. 2011; : 000132
        • Sever P.S.
        • Chang C.L.
        • Gupta A.K.
        • Whitehouse A.
        • Poulter N.R.
        The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK.
        Eur Heart J. 2011; 22: 2525-2532
        • Downs J.R.
        • Clearfield M.
        • Weis S.
        • Whitney E.
        • Shapiro D.R.
        • Beere P.A.
        • et al.
        Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
        JAMA. 1998; 279: 1615-1622
        • Colhoun H.M.
        • Betteridge D.J.
        • Durrington P.N.
        • Hitman G.A.
        • Neil H.A.
        • Livingstone S.J.
        • et al.
        Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
        Lancet. 2004; 364: 685-696
        • Elasy T.
        Improving diabetes outcomes: beyond glucocentricity.
        Clin Diabetes. 2008; 26: 1-2
        • Grundy S.M.
        • Vega G.L.
        • Yuan Z.
        • Battisti W.P.
        • Brady W.E.
        • Palmisano J.
        Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).
        Am J Cardiol. 2005; 95: 462-468
      2. Effects of combination lipid therapy in type 2 diabetes mellitus.
        N Engl J Med. 2010; 362: 1563-1574
        • Eliasson B.
        • Cederholm J.
        • Eeg-Olofsson K.
        • Svensson A.M.
        • Zethelius B.
        • Gudbjörnsdottir S.
        • National Diabetes Register
        Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes.
        Diabetes Care. 2011; 34: 2095-2100
        • Chan G.C.
        Type 2 diabetes mellitus with hypertension at primary healthcare level in Malaysia: are they managed according to guidelines.
        Singapore Med J. 2005; 46: 127-131
        • Davis D.
        • Goldman J.
        • Palda V.A.
        Handbook on clinical practice guidelines.
        Canadian Medical Association, Ottawa2007
        • Garg A.X.
        • Adhikari N.K.J.
        • McDonald H.
        • Rosas-Arellano M.P.
        • Devereaux P.J.
        • Beyene J.
        • et al.
        Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review.
        JAMA. 2005; 293: 1223-1238
        • Chan G.C.
        • Teng C.L.
        Primary care doctors’ perceptions towards evidence-based medicine in Melaka State: a questionnaire study.
        Med J Malaysia. 2005; 60: 130-133
        • Hudon C.
        • St-Cyr Tribble D.
        • Bravo G.
        • Poitras M.-E.
        Enablement in health care context: a concept analysis.
        J Eval Clin Pract. 2011; 17: 143-149
        • Siew Siang C.
        Medication adherence and achievement of glycaemic targets in ambulatory type 2 diabetic patients.
        J App Pharm Sci. 2011; : 55-59
        • Ramadas A.
        • Quek K.F.
        • Chan C.K.Y.
        • Oldenburg B.
        Web-based interventions for the management of type 2 diabetes mellitus: a systematic review of recent evidence.
        Int J Med Inform. 2011; 80: 389-405
        • van Dam Ha van der Horst F.G.
        • Knoops L.
        • Ryckman R.M.
        • Crebolder H.F.J.M.
        • van den Borne B.H.W.
        Social support in diabetes: a systematic review of controlled intervention studies.
        Patient Educ Couns. 2005; 59: 1-12
        • Deakin T.
        • McShane C.E.
        • Cade J.E.
        • Williams R.D.R.R.
        Group based training for self-management strategies in people with type 2 diabetes mellitus.
        Cochrane Database Syst Rev (Online). 2005; : CD003417
        • Vermeire E.
        • Wens J.
        • Van Royen P.
        • Biot Y.
        • Hearnshaw H.
        • Lindenmeyer A.
        Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus.
        Cochrane Database Syst Rev (Online). 2005; : CD003638